Utility of the MAYO end-stage liver disease score, King's College Criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure

被引:28
作者
Pelaez-Luna, M. [1 ]
Martinez-Salgado, J. [1 ]
Olivera-Martinez, M. A. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City 1400, DF, Mexico
关键词
D O I
10.1016/j.transproceed.2006.02.034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Several prognostic scores attempt to aid in the selection of patients with acute liver failure (ALF) to be treated either medically or by liver transplantation; however, their lack of fulfillment does not predict spontaneous survival in ALF and refined prognostic criteria are needed to improve such selection. Our aim was to evaluate and compare a new ALF in-hospital mortality prediction score versus King's College Criteria (KCC) and model for End-Stage Disease (MELD) score. Methods. First-time ALF-diagnosed individuals admitted to our institution (n = 58) were grouped according their final outcome as "alive" or "death," and those significantly different variables between groups entered into a logistic regression and lineal regression models. An ALF in-hospital mortality score (ALFIHMS) was produced and its sensitivity, specificity, and area under receiver operator characteristics were compared with those of KCC and MELD scores. Results. Since no significant differences (P = .81) in mortality rates between fulminant and subfulminant hepatic failure were found, no further analysis according to ALF's classification was performed. After obtaining and comparing ALFIHMS with KCC and MELD, we found that ALFIHMS prediction accuracy is higher than that of KCC and MELD score and that an ALFIHMS cutoff point > 15 points is associated with an in-hospital mortality probability > 50%. Conclusions. ALFIHMS has higher prognostic accuracy than KCC and MELD scores in ALF.
引用
收藏
页码:927 / 929
页数:3
相关论文
共 20 条
[1]  
ARNAD AC, 1997, J HEPATOL, V26, P62
[2]   MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN FULMINANT HEPATITIS-B [J].
BERNUAU, J ;
GOUDEAU, A ;
POYNARD, T ;
DUBOIS, F ;
LESAGE, G ;
YVONNET, B ;
DEGOTT, C ;
BEZEAUD, A ;
RUEFF, B ;
BENHAMOU, JP .
HEPATOLOGY, 1986, 6 (04) :648-651
[3]  
BERNUAU J, 1991, HEPATOLOGY, V14, pA49
[4]   FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES [J].
BERNUAU, J ;
RUEFF, B ;
BENHAMOU, JP .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :97-106
[5]   ORTHOTOPIC LIVER-TRANSPLANTATION IN FULMINANT AND SUBFULMINANT HEPATITIS - THE PAUL-BROUSSE EXPERIENCE [J].
BISMUTH, H ;
SAMUEL, D ;
CASTAING, D ;
ADAM, R ;
SALIBA, F ;
JOHANN, M ;
AZOULAY, D ;
DUCOT, B ;
CHICHE, L .
ANNALS OF SURGERY, 1995, 222 (02) :109-119
[6]  
DETRE K, 1994, CLIN TRANSPLANT, V8, P274
[7]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470
[8]  
KEEFFE EB, 2003, CURRENT DIAGNOSIS TR, P53
[9]  
Kramer L, 1998, HEPATOLOGY, V28, p495A
[10]  
LEE WM, 1995, HEPATOLOGY, V21, P101, DOI 10.1016/0270-9139(95)90415-8